WI SB83

Prohibits the Department of Health Services from imposing utilization management controls on FDA-approved antipsychotic prescription drugs under Wisconsin's Medical Assistance (Medicaid) program

Eliminates prior authorization and step therapy requirements for antipsychotic medications for Medicaid recipients

Utilization management controls include formal techniques evaluating prescription drug medical necessity, appropriateness, efficacy, or efficiency

Creates new section 49.45 (9o) of Wisconsin statutes governing antipsychotic drug access in Medicaid